Resting small B cells present endogenous immunoglobulin variable‐region determinants to idiotope‐specific CD4+ T cells in vivo

Antigenic determinants localized within the highly diversified V‐regions of Ig are called idiotopes (Id). Processed Id‐peptides can be presented on MHC class II molecules to CD4+ T cells. If B cells present their endogenous Id‐peptides, T cell activation could occur in the absence of nominal antigen...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of immunology Vol. 29; no. 12; pp. 4043 - 4052
Main Authors Munthe, Ludvig Andre, Kyte, Jon Amund, Bogen, Bjarne
Format Journal Article
LanguageEnglish
Published Weinheim WILEY‐VCH Verlag GmbH 01.12.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Antigenic determinants localized within the highly diversified V‐regions of Ig are called idiotopes (Id). Processed Id‐peptides can be presented on MHC class II molecules to CD4+ T cells. If B cells present their endogenous Id‐peptides, T cell activation could occur in the absence of nominal antigen, a potentially important process in T‐B cooperation and immune regulation. To test this idea, we used mice made transgenic for a λ2 L‐chain (Id+ mice). Another transgenic mouse strain expresses TCR transgenes with specificity for the Id (λ2), presented on MHC class II molecules. When highly purified sorted Id+ B cells and Id‐specific T cells were sequentially injected into MHC syngeneic SCID host, T cell became blastoid, CD69+ and proliferated. To exclude any role of host APC, MHC incompatible Rag2– / – mice (H‐2b) were used as recipients for the Id+ B and Id‐specific T cells, with similar results. Exposure to extracellular Id+ immunoglobulin (Ig) was not sufficient for Id priming of B cells in vivo, highlighting the preferential presentation of Id peptides derived from endogenous Ig, by B cells. The results suggest that B cells presenting Id self‐peptides generated by V(D)J recombinations or somatic mutations may directly stimulate T cell in vivo in the absence of conventional antigen.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-2980
1521-4141
DOI:10.1002/(SICI)1521-4141(199912)29:12<4043::AID-IMMU4043>3.0.CO;2-E